PubMed1 min read
Decoding Lung Cancer with Artificial Intelligence: A Path to Personalized Diagnostics and Therapy
Non-small-cell lung cancer (NSCLC) represents the majority of lung cancer cases and remains the leading cause of cancer-related mortality worldwide. Early detection, accurate staging, and individualized therapy are crucial for improving patient survival.
By Tafadzwa Carl MasukaPubMed - AI Research
Read the full story
Originally published by PubMed - AI Research on Oct 30, 2026.
Comments
Sign in to join the discussion.